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                        CLINICAL  PROFILE OF     
      STROKE       
                           1. INTRODUCTION      
      Stroke is an emerging epidemic and is the third leading  cause 
of death. The term stroke encompasses 1       
                        Cerebral infarction        
    Intra cerebral hemorrhage       
    Cerebral venous thrombosis      
    Subarachnoid hemorrhage       
             
    Based on a retrospective analyses of subjects admitted in  
urban  hospitals in India it was found that stroke constitutes nearly  2%  of all  
hospital cases and 20% of neurological admissions.2  The  incidence  in  younger 
population (below 40 years) is high (13 to 32%)  when compared  to European 
countries  
 
                       A  Random survey on 2,58,576 residents in urban areas of Vellore 
revealed only 147 hemiplegic subjects presumed to be  Vascular origin. Thus  the 
prevalence rate for hemiplegia in south India was reported to be 56.9 per 1,00,000 
as compared 150 to 186 per 1,00,000 for USA and Europe3      
 2      
       
       
       
       
       
       
  
2. AIM  OF  THE STUDY 
To study 200 cases of stroke with complete analysis of Age, Sex, 
Incidence, Types of stroke, other risk factors, Clinical presentation, Onset, 
Associated features, and  CT scan findings       
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                     3.REVIEW OF LITERATURE     
 DEFINITION         
  A stroke(cerebrovascularaccident) is a rapidly   developing  episode 
of focal and at times global  loss of    cerebral function    with  symptoms lasting 
more than 24hours or leading to death with no apparent  cause  other than that of 
vascular origin 4     
. 
                  Transient ischaemic attack (TIA) is an acute loss of   focal 
cerebral or  monocular function with symptoms   lasting less  than 24hours. 
                       
               Reversible ischaemic neurological deficit(RIND) refers to 
neurological deficit  that disappears within 2-3  days of onset  
             
      EPIDEMIOLOGY         
 
 
               RISK FACTORS 5  
 
                     NON-MODIFIABLE RISK FACTORS   
 
Age : Increasing age is most powerful riskfactor  for cerebral 
infarction , intracerebralhemorrhage and subarachnoidhemorrhage   as well as TIA  
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                 Sex : men are more at risk for ischaemicstroke than woman upto  75 
years of age. 
 
Race : the risk is more in Blacks than Whites    
  Family history : there is an increased incidence of stroke 
individuals who   have a first degree relative affected with stroke or  who 
havepaternal or maternal history of death or disability due to  stroke   
                        
     MODIFIABLE RISK FACTORS  5     
  Hypertension :  it is an important predisposing factor not only for  
cerebral  hemorrhage but also for infarction. Both systolic and diastolic pressures 
contribute to the risk though there is no critical level above which it operates The 
reduction of BP by 10-12mmHg systolic and 5-6mmHg diastolic was found to be 
associated with 38% reduction in stroke incidence.      
                Diabetes mellitus : it is an independent risk factor for stroke. It 
increases the susceptibility to coronary , femoral , and cerebral atherosclerosis. 
The relative risk increases two to fourfold in diabetics patients with diabetic 
complications like retinopathy and autonomic neuropathy have a higher incidence 
of ischemic stroke.          
     Hypercholesterolaemia :  it is a secondary risk factor indirectly   
    5 
 affecting the risk of stroke. Reducing high cholesterol levels decreases the 
incidence   of coronary artery disease which is the main cause mortality in patients 
with cerebrovascular disease.         
    Nonvalvular atrial fibrillation : is common in the age group of  
65 –  85  years attributes to a five fold increase in the incidence of embolic stroke     
especially in   those patients who have recent CCF , arterial hypertension and    
prior   thromboembolism         
  Cigarette smoking : increases ischemic stroke in men and women 
by predisposing to carotid atherosclerosis. Smokers experience a reduction in  
stroke  risk only after 5 years following cessation of smoking.    
    Alcohol : light to moderate use reduces the risk by increasing the   
HDL concentration, where as heavy drinking increases the risk more than on  
alcoholic drink per day for women and more than two per day men raises the BP  
causes obesity and triglycerides levels thereby increasing the risk.                
      TIA :  three times greater risk for subsequent stroke or death due   
to vascular causes ,especially those with hemispherical TIAs.patients with a  
previous history of stroke are at risk for a subsequent stroke. The risk of   stroke 
recurrence is increased by the presence of dementia 
 Carotid artery stenosis : Asymptamatic  Carotid artery stenosis   
less than 75% carries a risk of 1.3% annually where risk increases to 10.5%  per 
year if the stenosis is greater than 75%. Ulcerated .echoluscent and heterogenous 
    6 
plaques with a softcore are at higher risk for embolism.     
  Blood factors : Elevated haematocrit , haemoglobin and viscosity  
of the blood is associated with increased risk of  ischemic stroke. High mean  
levels of plasma fibrinogen, factor VIII , von willebrand’s factor, anti-thrombin III 
and lower mean levels of protein C  is   associated with   increased risk  The 
antiphospholipid antibodies is associated with increased  risk of  ischemic stroke 
Serum folate concentration less than or equal to 9.2   nmol/L alone may be risk  
factor  ischemic stroke  
             Hormones : high dose estrogen oral contraceptives increase the 
risk   of stroke in young women , while postmenopausal estrogen supplementation 
reduces the risk. The risk of cerebral infarction is increased in the 6 weeks   
following delivery          
     Others : abdominal or truncal obesity, physical inactivity, habitual   
snoring are associated with increased risk of  ischemic stroke 
   PATHOPHYSIOLOGY      
    
               stroke is 90% ischemic and 10 % hemorrhagic.6 Abrupt disturption 
of  focal cerebral blood flow causes acute ischemic stroke .The causes of 
decreased   cerebral blood flow include abrupt occlusion of small penetrating 
arteries  arterioles, single or multiple arterial stenoses, arteritis, arterial dissection, 
venous    occlusion, and profound anaemia. 
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                 When cerebral blood flow falls below a critical value of 20ml 
/100g/min there is a loss of neuronal electrical function which is a reversible 
stage.when cerebral blood flow falls below a critical value of 10ml / 100g/min 
then   aerobic   mitochondrial metabolism fails and anaerobic metabolism leads to    
lactic   acidosis.           
    As a sequel to this sodium and water enters the cell and potassium 
leaks   out of  the cell due to failure of energy dependent intracellular 
homoeostasis  leading to  irreversible cell death.      
 Based on these facts the concept of ischemic penumbra was 
formulated. It is   an area of brain that has reached the reversible stage of electrical 
failure but has not yet passed into the irreversible stage. Thrombolytic  agents are 
used in this time window to salvage the ischemic penumbra  zone. 
 
   Common causes 
 
   Thrombosis 
 
          Lacunar stroke (small vessel) 
 
          Large vessel thrombosis 
 
           Dehydration 
 
   Embolic occlusion 
 
         Artery-to-artery 
 
                        Carotid bifurcation 
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                     Aortic arch 
 
                  Arterial dissection 
 
         Cardioembolic 
 
                     Atrial fibrillation 
 
                     Mural thrombus 
 
                     Myocardial infarction 
 
                    Dilated cardiomyopathy 
 
                    Valvular lesions 
 
                            Mitral stenosis 
 
                            Mechanical valve 
 
                           Bacterial endocarditis 
 
             Paradoxical embolus 
 
                          Atrial septal defect 
 
                           Patent foramen ovale 
 
            Atrial septal aneurysm 
  
              Spontaneous echo contrast 
 
      Uncommon causes 
 
              Hypercoagulable disorders 
 
                        Protein C deficiency 
 
                           Protein S deficiency 
 
                         Antithrombin III deficiency 
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                        Antiphospholipid syndrome 
 
                         Factor V Leiden mutation 
 
                       Prothrombin G20210 mutation 
 
                       Systemic malignancy 
 
                       Sickle cell anemia 
 
                       Beta Thalassemia 
 
                       Polycythemia vera 
 
                       Systemic lupus erythematosus 
 
                       Homocysteinemia 
 
                      Thrombotic thrombocytopenic purpura    
  
                       Disseminated intravascular coagulation 
 
                      Dysproteinemias 
 
                       Nephrotic syndrome 
 
                       Inflammatory bowel disease 
 
                      Oral contraceptives 
 
                        Venous sinous thrombosis 
 
                        Fibromuscular dysplasia 
 
                        Vasculitis 
 
                            Systemic vasculitis 
                                     (PAN, Wegner's, Takayasu's, giant cell  arteritis )  
                                                                                             
                     Primary CNS vasculitis 
 
 Meningitis (syphilis, tuberculosis, fungal, bacterial, zoster) 
    10 
 Cardiogenic 
 
Mitral valve  calcification 
 
  Atrialmyxoma 
 
  Intra cardiac tumor 
 
  Marantic endocarditis 
 
  Libman-Sacks endocarditis 
 
Subarachnoid hemorrhage vasospasm 
 
Drugs: cocaine, amphetamine 
 
Moyamoya disease 
 
Eclampsia     
                 
 
     CLINICAL SYNDROMES 5 
 
      TRANSIENT ISCHAEMIC ATTACKS    
 
                   TIAs are abrupt in onset , brief in duration  and recovery is possible  
  
   in  24 hours . Recurrent TIAs can occur. Recognition and treatment is  important  
 
   as a complete stroke can be prevented. 
 
      Carotid  TIAs          
   These are characterized by monocular blindness with recovery 
within     Few minutes, visual field disturbance in the form of transient hemianopia 
and   speech disturbance due to dominant hemispherical dysfunction.  Hemiparesis 
and hemisensory loss can occur both in vertebro basilar   TIAs  as well as carotid 
TIAs.  
     11 
   Vertebrobasilar TIAs         
           
            These are characterized by prominent visual symptoms like 
Diplopia, homonymous hemianopia and cortical blindness, transient vertigo and 
dizziness, unsteadiness due to cerebellar dysfunction. And transient lower cranial 
nerve symptoms like dysarthria, perioral numbness, nasal regurgitation.  
     Drop attacks occur without any warning .It is thought to be due to 
 ischemia of relays in reticular systems which normally function as part of reflex  
antigravity mechanism. 
       Subclavian steal 
 
             This syndrome occurs when there is occlusion of the Subclavian 
artery proximal to origin of vertebral artery which results in retrograde flow of 
blood down the vertebral artery during exercising the arm thereby leading on to 
symptoms of hindbrain ischaemia.        
 Ministrokes          
    Ministrokes are characterized by episodic ischaemic symptoms 
which  recover within  24 hours but there are small infarcts or hemorrhage in CT. 
They  are  as significant as the TIAs 
 Stroke in  evolution 
 
            Stroke in  evolution refers to the slow progression of 
neurological deficit  over several hours.        
  Major strokes 
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             Major stroke are of sudden onset with loss of consciousness at the 
onset or   soon after it is very difficult to distinguish clinically between infarction 
or    hemorrhage. Headache and vomiting if present, usually denotes hemorrhage  
if associated with rapid loss of consciousness. Atherothromboembolism is   
suggested by the presence of bruit over the carotid arteries.    
  Unusual  types of stroke 
 
          Multi-infarct dementia 
       
           Watershed infarction      
 
 
                  
Classification of stroke on the basis of oxfordshire community stroke  
 
Sub classification 7 
 
       Total anterior  circulation syndrome (TACS) 
           
    Implies a large cortical stroke in middle cerebral or middle and 
anterior   cerebral artery territories.it is characterized by a combination of 
 new higher cerebral dysfunction 
 
 Homonymous visual field defect 
 
 an ipsilateral motor and / or sensory deficit involving at least 
two out of  three areas of the face , arm or leg     
    Partial  anterior  circulation syndrome 
           
   Implies a cortical stroke in middle or anterior cerebral arterial  
    13 
territory . They are patients with two out of three   components  of   the      Total    
anterior  circulation syndromes or new higher cerebral dysfunction alone or    
motor / sensory deficit more restricted than those classified as a TACS .   
   Lacunar syndrome 
 
           Implies a subcortical stroke due to a small vessel disease 
 
•  Pure motor stroke 
 
•  Pure sensory stroke 
 
•  sensory motor stroke 
 
•  ataxic hemipaesis   
 
  evidence of higher cortical dysfunction or disturbance of consciousnes   excludes  
Lacunar syndrome            
posterior circulation syndrome 
      ipsilateral cranial nerve palsy with contralateral motor and sensory deficit       
bilateral   motor and  / or sensory deficit  disorder of conjugate eye   movement 
cerebellar dysfunction without ipsilateral long tract involvement isolated 
homonymous visual field defects 
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ANTERIOR CEREBRAL CIRCULATION SYNDROME 
 
 
no Signs and symptoms Structures involved 
1. Paralysis of opposite foot and leg Motor leg area 
2. Lesser degree of paresis of opposite arm Involvement of cortical / 
corona radiata of arm fibres 
3. Cortical sensory loss over toes, foot and leg Sensory area for foot and 
leg 
4. Urinary incontinence Sensory motor area in para 
central lobule 
5. Contralateral grasp reflex,suckling reflex, 
gegenhalten 
Medial surface of the 
posterior frontal lobe 
6. Abulia,slowness,delay,intermittentinterruption, 
lackofspontaneouslywhispering,reflex 
distraction to sights and sounds 
Cingulatedgyrus,medial 
inferiorportion of frontal, 
parietal and temporal lobes 
7. Impairement of gait and stance (gait apraxia) Frontal cortex near leg 
motor area 
8. Dyspraxia of left limbs, Tactile aphasia in left 
limbs 
Corpus callosum 
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   MIDDLE CEREBRAL CIRCULATION SYNDROME 
 
no Signs and symptoms Structures involved 
1 Paralysis of the contralateral face, 
arm, and leg; sensory impairment 
over the same area (pinprick, cotton 
touch, vibration, position, two-point 
discrimination, stereognosis, tactile 
localization, barognosis, 
cutaneographia) 
Somatic motor area for face and 
arm and the fibers descending 
from the leg area to enter the 
corona radiata and 
corresponding somatic sensory 
system 
 
2 Motor aphasia Motor speech area of the 
dominant hemisphere 
3 Central aphasia, word deafness, 
anomia, jargon speech, sensory 
agraphia, acalculia, alexia, finger 
agnosia, right-left confusion (the last 
four comprise the Gerstmann 
syndrome 
Central, suprasylvian speech 
area and parietooccipital cortex 
of the dominant hemisphere 
 
4 Conduction aphasia Central speech area (parietal 
operculum) 
5 Apractognosia of the minor 
hemisphere (amorphosynthesis), 
anosognosia, hemiasomatognosia, 
unilateral neglect, agnosia for the left 
half of external space, dressing 
"apraxia," constructional "apraxia," 
distortion of visual coordinates, 
inaccurate localization in the half 
field, impaired ability to judge 
distance, upside-down reading, visual 
illusions (e.g., it may appear that 
another person walks through a table) 
Nondominant parietal lobe (area 
corresponding to speech area in 
dominant hemisphere); loss of 
topographic memory is usually 
due to a nondominant lesion, 
occasionally to a dominant one 
6 Homonymous hemianopia (often 
homonymous inferior 
quadrantanopia) 
Optic radiation deep to second 
temporal convolution 
 
7 Paralysis of conjugate gaze to the 
opposite side 
Frontal contraversive field or 
projecting fibers 
 
   
      16 
    POSTERIOR CEREBRAL CIRCULATION SYNDROME 
 
   Peripheral territory 
 
no Signs and symptoms Structures involved 
1 Homonymous hemianopia (often upper 
quadrantic) 
Calcarine cortex or optic 
radiation 
2  Bilateral homonymous hemianopia, 
cortical blindness, awareness or denial 
of blindness; tactile naming, 
achromatopia (color blindness), failure 
to see to-and-fro movements, inability to 
perceive objects not centrally located, 
apraxia of ocular movements, inability 
to count or enumerate objects, tendency 
to run into things that the patient sees 
and tries to avoid 
 Bilateral occipital lobe with 
possibly the parietal lobe 
involved 
4 Verbal dyslexia without agraphia, color 
anomia 
 Dominant calcarine lesion 
and posterior part of corpus 
callosum.  
5  Memory defect Hippocampal lesion 
bilaterally or on the 
dominant side only 
6 Topographic disorientation and 
prosopagnosia 
nondominant, calcarine, and 
lingual gyrus. 
7  Simultagnosia, hemivisual neglect  Dominant visual cortex, 
contralateral hemisphere 
8  Unformed visual hallucinations, 
peduncular hallucinosis, 
metamorphopsia, teleopsia, illusory 
visual spread, palinopsia, distortion of 
outlines, central photophobia 
Calcarine cortex. 
9 Complex hallucinations nondominant hemisphere. 
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  POSTERIOR CEREBRAL CIRCULATION SYNDROME 
 
Central territory          
  
no Signs and symptoms Structures involved 
1 Thalamic syndrome: sensory loss (all 
modalities), spontaneous pain and 
dysesthesias, choreoathetosis, intention 
tremor, spasms of hand, mild hemiparesis 
Posteroventral nucleus of 
thalamus; involvement of 
the adjacent subthalamus 
body or its afferent tracts 
2 Thalamoperforate syndrome: crossed 
cerebellar ataxia with ipsilateral third 
nerve palsy (Claude's syndrome) 
 Dentatothalamic tract and 
issuing third nerve 
3 Weber's syndrome: third nerve palsy and 
contralateral hemiplegia 
Third nerve and cerebral 
peduncle 
4 Contralateral hemiplegia Cerebral peduncle 
5  Paralysis or paresis of vertical eye 
movement, skew deviation, sluggish 
pupillary responses to light, slight miosis 
and ptosis (retraction nystagmus and 
"tucking" of the eyelids may be 
associated) 
Supranuclear fibers to third 
nerve, interstitial nucleus of 
Cajal, nucleus of 
Darkschewitsch, and 
posterior commissure 
6  Contralateral rhythmic, ataxic action 
tremor; rhythmic postural or "holding" 
tremor (rubral tremor) 
 Dentatothalamic tract 
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     DIAGNOSTIC EVALUATION OF ISCHAEMIC STROKE 8 
 
     The diagnostic evaluation should include parallel assessment of the following. 
 
           1.  Imaging of the infarct 
 
           2.  vascular studies 
 
           3.  cardiac evaluation 
 
           4.  Haematological and other blood testing 
 
          Imaging          
  CT scan brain is done to differentiate hemorrhage from infarction 
Investigations  must be ordered based on the possible etiology.Cerebral 
arteriography is needed if intra arterial thrombolysis is contemplated. Angiogram 
is done if vascular stenosis is suspected if it is negative or if  Posterior circulation  
is suspected then ,TransCranial Doppler is done.     
  
 CT versus MRI 
 
1. only a minority infarction demonstrated within 24 hours on CT. 
 
MRIdocument infarct as early 6 hours 
 
2. anatomic extent and vascular distribution are better delineated in MRI. 
 
Small infarctions are easily seen. 
 
3. posterior fossa infarctions are better visualized in MRI 
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    CT scan changes in cerebral   infarction 9 
 
           Hyper acute infarct < 12 hours 
 
•  normal (50 – 60%) 
 
• Hyper dense artery(25 – 50%) 
 
• Obscuration of lentiform nuclei 
 
            Acute infarct 12 to 24hours 
 
• Low density basal ganglia 
 
• Loss of grey white interfaces 
 
• Sulcal effacememt 
 
           1 to 3days 
 
• Increasing mass effect 
 
•Wedge shaped low density area that involves both grey and   
 
                                                                               Whitematter 
 
•Hemorrhagic transformation may occur(basalganglia and cortex are  
 
common sites) 
 
            4 to  7days 
 
• Gyral enhacement 
 
• mass effect, oedema persist 
 
            1 to 8 weeks 
 
• Contrast enhacement persists 
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• mass effect resolves 
 
           months to years  
 
• encephalomalacicchanges 
 
• volume loss 
 
• calcification rare 
 
 
           Neurological  Pearls In Prognosis 
 
                    predictors of stroke outcome 10 
     
           factors predicting poor outcome 
 
1. age : more than 75 years 
 
2. males : due to lack oestrogen protective effect 
 
3. risk factors : atrial fibrillation , DM , previous stroke 
 
4. clinical findings   
 
•  decreased consciousness at the onset 
 
• Presence of gaze deviation 
 
• Headache , nausea ,vomiting in first 24 hours 
 
• Elevated systolic BP >180 mm Hg on first day 
 
• Hyperthermia on admission 
 
• NIHSS score of 16 or more 
 
• Large vessel disease 
 
           5. laboratory findings 
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• High glutamine in plasma > 200 micromol / L 
 
 
• CRP concentration > 10.2 mg / l within 72 hours 
 
• Hyperglycaemia > 7mmol / l 
 
• Platelet count < 150000 due to increased bleeding 
 
        6.neuro imaging studies 
 
•  Hyper density in a major intra cranial artery 
 
• Early CT changes within 6 hours of onset 
 
• >33 % of MCA territory involvement / multiple territory involvement    
with mass effect 
 
• Hemorrhagic transformation on follow up CT / on intra cranial  
 
                      Doppler persisting MCA occlusion for hours 
 
• No flow on SPECT perfusion patterns 
 
• Carotid artery occlusion on conventional angiogram 
 
 
• MCA , basilar artery occlusion on angiogram 
 
• MRI – abnormal PWI in diffusion and perfusion weighted imaging 
 
• MRA – absence of MCA is associated with poor prognosis 
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                            TREATMENT       
The first goal is to prevent or reverse brain injury 
 
                          The second goal is to obtain an accurate understanding of 
the stroke mechanism so one can halt progression of brain injury or begin to 
prevent  a second stroke 
 
 Treatments designed to reverse or lessen the amount of tissue infarction fall   
  
  within   five categories: 
 
(1) Medical support 
 
(2)  Thrombolysis, 
 
(3)  Anticoagulation 
 
(4) Antiplatelet agents, and 
  
(5) Neuroprotection. 
 
 
 
  Medical Support         
    1. When cerebral infarction occurs, the immediate goal is to optimize 
cerebral perfusion in the surrounding ischemic area    
   2 . Preventing the common complications of bedridden patients 
    infections (pneumonia, urinary tract, and skin) and  
              deep venous thrombosis with pulmonary embolism.  
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3. Elevated blood pressure should not be lowered unless there is  
 
malignant hypertension or concomitant myocardial ischemia.  
   If the blood pressure is low, raising it is advisable, using 
intravenous fluids or vasopressor drugs to enhance perfusion within the 
ischemic penumbra. 
 
             4. treatment  of cerebral edema if necessary  
 
 
     Thrombolysis          
            
                    The use of thrombolytic agents in acute cerebral infarction has been  
studied extensively. 
   Angiography performed within a few hours of infarction frequently  
demonstrates arterial occlusions corresponding to patients presenting signs and   
symptoms. It is this association of arterial occlusion with acute neurologic   
symptoms that prompted the study of thrombolytic agents in stroke patients. 
   Agent used for this purpose is intravenous recombinant tissue 
 
      plasminogen activator (rtPA) 
 
      Indication 11 
 
            Clinical diagnosis of stroke 
 
           Onset of symptoms to time of drug administration 3 h 
 
           CT scan showing no hemorrhage or significant edema 
 
           Age 18 years 
       24 
              Consent by patient or surrogate 
 
 
           Administration of rtPA 12 
              
              Intravenous access with two peripheral IV lines 
                              (avoid arterial or central  placement) 
 
              Review eligibility for rtPA 
 
           Administer 0.9 mg/kg intravenously (maximum 90 mg) IV as 10% of total    
dose  by bolus, followed by remainder of total dose over 1 h 
              Continous cuff blood pressure monitoring  
 
              No other antithrombotic treatment for 24 h 
 
              For decline in neurologic status or uncontrolled blood pressure, stop  
 
              infusion,  give cryoprecipitate, and reimage brain emergently 
 
               Avoid urethral catheterization for > 2 h 
 
          Contraindication 11 
 
             Sustained BP > 185/110 
 
             Platelets <  100,000; HCT<  25%; glucose < 50 or > 400 
 
             Use of heparin within 48 h and prolonged PTT, or elevated INR 
 
             Rapidly improving symptoms 
 
             Prior stroke or head injury within 3 months; prior intracranial  
                                                                                              hemorrhage 
             Major surgery in preceding 14 days 
 
             Minor stroke symptoms 
 
             Gastrointestinal bleeding in preceding 21 days 
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             Recent myocardial infarction 
 
               Coma or stupor 
 
 
        Anticoagulation         
    The role of anticoagulation in atherothrombotic cerebral ischemia 
is   uncertain.   Heparinization is generally accomplished by beginning an infusion  
without bolus and is monitored to maintain the activated PTT at approximately    
twice normal.         
     This regimen is maintained for 2 to 5 days. During this time the 
patient is  monitored for hemorrhagic complications, the evaluation is completed      
decision is made regarding the need for carotid endarterectomy, long-term 
anticoagulation, or an antiplatelet therapy.      
    If long-term anticoagulation is chosen, warfarin is administered 
and   heparin discontinued when the international normalized ratio (INR) is in the  
 range  of 2 to 3. 
 
       Antiplatelet Agents         
    Aspirin is the only antiplatelet agent that has been prospectively   
studied for the treatment of acute ischemic stroke.  The use of aspirin within 48 h 
of stroke onset reduced both stroke recurrence risk and mortality minimally       
Neuroprotectio          
   Neuroprotection is the concept of providing a treatment that  
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prolongs    the brain's tolerance to ischemia long enough to allow other measures 
to be employed to mitigate ischemia. 
                  Hypothermia is probably the most powerful neuroprotectant but is only 
now the subject of clinical trials. 
Primary and Secondary Prevention 
 
             Atherosclerosis Risk Factors   
 
                  Hypertension is the most significant of the risk factors; in general, 
all hypertension should be treated. coronary artery disease is the most common 
cause of death in patients with cerebrovascular disease, treatment of 
hypercholesterolemia seems prudent for both the heart and brain.Tobacco 
smoking should be discouraged in all patients       
         Antiplatelet Agents          
   Platelet antiaggregation agents can prevent atherothrombotic 
events,  including TIA and stroke, by inhibiting the formation of intraarterial 
platelet aggregates. These can form on diseased arteries, induce thrombus 
formation, andocclude the artery or embolize into the distal circulation. 
 
                 Aspirin,  
 
                 clopidogrel, and  
 
                 The combination of aspirin plus extended-release dipyridamole are 
the  antiplatelet agents used most for this purpose. 
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            EMBOLIC STROKE           
warfarin is more effective than aspirin in preventing ischemic stroke    associated 
with atrial fibrillation.  
Anticoagulation Therapy 
 
           ATHEROTHROMBOTIC STROKE   
        
                There are few data to support the use of long-term  warfarin  for 
preventing  atherothrombotic stroke, either intracranially or extracranially. 
           
   EMBOLIC STROKE   
 
 Several recent trials demonstrated that anticoagulation (INR range 2 
to 3) in  patients with chronic nonvalvular (nonrheumatic) atrial fibrillation 
prevents cerebral embolism and is safe.       
      For primary prevention and for patients who have experienced 
stroke or TIA, anticoagulation with warfarin reduces the risk by about 65% and 
clearly   outweighs the 1% per year rate of major bleeding complication. 
 Because of the high annual stroke risk in untreated rheumatic heart 
disease,  primary prophylaxis against stroke has not been studied in a double-   
blind fashion. These patients generally receive long-term anticoagulation. 
    Anticoagulation also reduces the risk of embolism in acute 
myocardial infarction. Most clinicians recommend a 3-month course of 
anticoagulation when there is anterior Q-wave infarction,substantial  Left  
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 ventricular dysfunction ,congestive heart failure, muralthrombosis, or atrial 
fibrillation .Warfarin is recommended long-term if atrial fibrillation persists.     
Thromboembolism is one of the most serious complications of prosthetic heart 
valve implantation. Anticoagulation has been proven effective for preventing 
strokes in this situation, while antiplatelet therapy alone has not.   
  However, coupled with warfarin anticoagulation, aspirin adds 
substantial benefit. A greater degree of anticoagulation (INR of 3 to 4, depending 
on valve type) is recommended for prosthetic heart valve patients. 
 
            SURGICAL THERAPY  
 
                                    Surgery for atherosclerotic occlusive disease is largely 
limited to carotid endarterectomy for plaques located at the origin of the internal 
carotid artery in the neck  
   Carotid endarterectomy is a proven effective 
prophylaxisagainst stroke and TIA.  
              Stroke Centers and Rehabilitation     
   
                          Comprehensive stroke units that care for the acute patient     
followed by rehabilitation services have been shown to improve neurologic 
outcomes and reduce mortality       
        Proper rehabilitation of the stroke patient includes early 
physical, occupational, and speech therapy. It is directed toward educating     the  
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patient and family about the patient's neurologic deficit, preventing the 
complications of immobility (e.g., pneumonia, deep vein thrombosis and 
pulmonary embolism,pressure sores of the skin, muscle contractures), and 
providing encouragement and instruction in overcoming the deficit. The goal of 
rehabilitation is to return the patient to home and to maximize recovery by 
providing a safe, progressive regimen suited to the individual patient 
 
                   INTRA CEREBRAL HEMORRHAGE 
             
                          Intra cerebral hemorrhage accouts for approximately 15% of the 
strokes. The overall mortality for this type subtype of stroke is from 25 % to 60%   
In nearly  70% of patients Hypertension is the commonest cause.  
   The lipohyalinosis of the small intraparenchymal arteries is the 
leading cause of  hemorrhage.       
  The microaneurysms of charcot and  bouchard is uncertain,but they 
are found at anatomical sites preferentially affected by ICH. 
 
 The non Hypertensive causes include following : 
 
1. bleeding disorders, anticoagulant and fibrinolytic treatment 
 
2. cerebral amyloid angiopathy 
 
3. granulomatous angiitis  of the CNS 
 
4. sympathomimetic agents 
 
5. trauma  
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6. hemorrhagic infarction 
 
7. vascular malformations 
 
8. intra cranial tumours 
 
clinical features: 
     
      symptoms of increased  ICT 
 
      symptoms that are specific for the location of the haematoma 
 
      focal neurological deficits 
 
 
Imaging 
 
The  CT scan is sensitive to the high density fresh blood in the 
parenchyma while MRI can determine the time duration between the    
hemorrhage and the MRI examination 
 
 common  sites : 
 
     1 . putamen  
 
     2 . lobar 
 
     3 . thalamus 
 
     4 . caudate nucleus 
 
     5 . pons 
 
     6. cerebellum 
 
   Treatment  
 
        Control of hypertension 
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        Air way maintenance if the GCS is less than 8 
 
       Treatment of coagulation abnormalities 
 
                 Protamine sulfate is used if the  hemorrhage is due to heparin 
Cryoprecipitate is used if the  hemorrhage is due to heparin   
     Measures for the prevention of further elevation of  ICP  
     Routine  anticonvulsants not recommended in patients who do not have  
seizures at onset due to negligible risk of subsequent epilepsy in them 
    Patients with  lobar hemorrhage and cerebellar hemorrhage can be 
managed surgically whereas the deep hemorrhages are managed medically. 
 
                              SUBARACHNOID HEMORRHAGE 
 
            Causes 
 
              Head trauma, 
  
             Rupture of a saccular aneurysm. the most common cause 
 
             Bleeding from a vascular anomaly and  
 
             Extension into the subarachnoid space from a primary  ICH 
 
             Idiopathic SAHs . 
 
            Clinical Manifestations   
 
               Headache 
 
                         "the worst headache of my life." 
                                 
                                 sudden headache in the absence of focal neurologic 
 symptoms is the hallmark of aneurysmal rupture  
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             Delayed neurologic deficits  
  
              There are four major causes of delayed neurologic deficits; 
 
                             Rerupture,  
 
                             Hydrocephalus, 
 
                             Vasospasm, and 
 
                             Hyponatremia. 
 
 
              Laboratory Evaluation and Imaging      
  
                          The hallmark of aneurysmal rupture is blood in the CSF,more 
than 95% of cases have enough blood to be visualized on a  high-quality 
noncontrast CT scan obtained within 72 h.      
    If the scan fails to establish the diagnosis of SAH and no mass 
lesion or obstructive hydrocephalus is found, an LP should be performed to 
establish   thepresence of subarachnoid blood. Lysis of the red blood cells and 
subsequent  conversion of hemoglobin to bilirubin stains the spinal fluid yellow 
within 6 to   12 h of SAH. This xanthochromic spinal fluid peaks in intensity at 48 
h and   lasts for1 to 4 weeks, depending on the amount of subarachnoid blood
     Four-vessel conventional x-ray angiography (both carotids and    
both vertebrals) is generally performed to localize and define the anatomic   
details  of the aneurysm and to determine if other unruptured aneurysms exist..
  The ECG frequently shows ST-segment and T-wave changes  similar to 
those associated with cardiac ischemia. Prolonged QRS complexincreased QT  
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interval, and prominent "peaked" or deeply inverted symmetric T  waves are 
usually secondary to the intracranial hemorrhage.  Serum electrolytes are obtained 
because hyponatremia may   develop.      
     Close monitoring (daily or twice daily) of serum sodium is 
important  since hyponatremia can occur precipitously during the first 2 weeks 
following  SAH  .         
   TCD ultrasound assessment of proximal middle, anterior, and  
posterior cerebral and basilar artery flow is helpful in detecting the onset of  
vasospasm and in following its course and response to therapy. 
    TREATMENT         
  
               The medical management of SAH centers on airway protection, 
blood pressure management before and after aneurysm treatment, preventing  
rebleeding prior to treatment, managing vasospasm, treating hydrocephalus, and 
treating hyponatremia.        
       An aneurysm can be "clipped" by a neurosurgeon or "coiled" by 
a   neurointerventional radiologist       
  Patients who are stuporous should undergo emergent  
ventriculostomy to prevent cerebral ischemia from high ICP. Medical therapies 
designed to combat raised ICP (e.g., mild hyperventilation, mannitol, and 
sedation) can also be used as needed  
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                       All patients who are not candidates for early surgical treatment 
areput on bed rest in a quiet, preferably darkened, room and are given stool 
softeners to prevent constipation. 
Adequate hydration is necessary to avoid a decrease in blood   volume 
predisposing to brain ischemia.       
    Phenytoin is often given as prophylactic therapy since a seizure may  
promote rebleeding. 
     Glucocorticoids may help reduce the head and neck ache caused by the 
irritative effect of the subarachnoid blood.      
   Vasospasm remains the leading cause of morbidity and mortality 
following aneurysmal SAH and treatment of the aneurysm. Treatment with the 
calcium channel antagonist Nimodipine (60 mg orally q6h)  is beneficial. 
The most widely accepted therapy for symptomatic cerebral vasospasm is 
to increase the cerebral perfusion pressure by raising mean arterial pressure 
through plasma volume expansion and the judicious use of vasopressor 
agentsusually phenylephrine or dopamine. 
                  Volume expansion helps prevent hypotension, augments cardiac 
output, and reduces blood viscosity by reducing hematocrit. This method is called 
"triple-H" (hypertension, hemodilution, and hypervolemic) therapy.  
      If   symptomatic   vasospasm    persists   despite  optimal   medical  
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 therapy, Intra arterial papaverine and percutaneous transluminal 
angioplasty are considered.  
When chronic hydrocephalus develops, ventricular shunting is the 
treatment of choice.         
 Free-water restriction is contraindicated in patients with SAH at risk for   
vasospasm because hypovolemia and hypotension may occur and precipitate   
cerebral ischemia. 
All patients should have pneumatic compression stockings applied to 
prevent pulmonary embolism. 
 
                       CEREBRAL VENOUS THROMBOSIS 
 
            Venous sinus thrombosis of the lateral or sagittal sinus or of small     
  
   cortical veins (cortical vein thrombosis)  
                                  
 
   Causes 
 
           pregnancy and the postpartum period 
 
           sepsis   
 
           intracranial infections (meningitis) 
 
           thrombophilia 
 
           polycythemia 
 
           sickle cell anemia 
 
           proteins C and S deficiency 
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           factor V Leiden mutation (resistance to activated protein C) 
 
           antithrombin III deficiency 
 
           homocysteinemia 
 
           prothrombin G20210 mutation. 
 
           oral contraceptives 
 
 
  Clinical features 
 
        headache   
 
        focal neurologic signs  
 
        seizures 
 
       signs of increased ICP  
 
        coma 
 
 
Imaging 
 
CT imaging is normal unless an intracranial venous hemorrhage 
 
MR venography or conventional x-ray angiography. 
 
Treatment  
 
      Intravenous heparin 
 
      Warfarin for 3 to 6 months 
 
       Aspirin  
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              4.MATERIALS AND METHODS  
 
    1. 200 cases  of stroke in government  Stanley medical college between     
september2005 to february 2006 
   2. Complete history , physical examination  were done and clinical diagnosis
 of  the  patient  was arrived 
   3.  All  patients BP , bloodsugar , urea ,serum creatinine , electrolytes , total    
cholesterol  X ray chest , ECG , hemoglobin , total and differential count , and   
associated  Diseases were noted             
4. if  associated diseases were noted further special work up was done 
5 . CT brain plain was done for all patients 
6 . contrast enhancement CT brain was done as advised by radiologist 
7 . MRI brain was done as advised by neurologist 
8 . the results of all the data are expressed in the tabular forms  for analysis 
 
 Excluded cases 
 
         Cerebral tumour 
 
         Cerebral abscess 
 
         Tuberculoma brain 
 
         Old CVA admitted for other diseases 
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                             5 . OBSERVATIONS 
 
             TABULATIONS  
                     
 
             SEX DISTRIBUTION    Table ( 5.1 ) 
 
                              
Sex No of cases % 
male 140 70% 
female 60 30% 
 
 
                       
 
           AGE WISE DISTRIBUTION  Table ( 5. 2 ) 
 
 
              
Age Male Female Total % 
< 30 6 4 10 5% 
31 - 40 14 6 20 10% 
41 - 50 18 4 22 11% 
51 - 60 50 18 68 34% 
61 - 70 38 20 58 29% 
71 - 80 10 6 16 8% 
>80 4 2 6 3% 
 140 60 6 100% 
      SEX DISTRIBUTION Fig(5.1) 
 
 
male
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      AGE WISE DISTRIBUTION  Fig (5.2) 
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      39 
 
 
 INCIDENCE OF STROKES ( table 5 . 3 ) 
 
  
Incidence of strokes Male % Female % Total 
Ischemic stroke * 114 57% 48 24% 81% 
Intra cerebral hemorrhage 26 13% 10 5% 18% 
Cerebralvenousthrombosis - - 2 1% 1% 
subarachnoid hemorrhage - - - -  
 
* cerebral infarction ,TIA, cerebellar infarct 
 
 
 
 
 
TYPES OF STROKE ( table5 . 4 ) 
 
 
Types of stroke 
 
Male % Female % total 
Cerebral infarction 104 52% 40 20% 72% 
TIA 8 4% 8 4% 8% 
Cerebellar infarct 2 1% - - 1% 
Intra cerebral hemorrhage 26 13% 10 5% 18% 
Cerebral venous thrombosis - - 2 1% 1% 
subarachnoid hemorrhage - - - - - 
 
 
 
 
 
       AGE AND SEX WISE DISTRIBUTION  Fig (5.3) 
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      INCIDENCE OF STROKES Fig (5.4) 
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RISK FACTORS  ( table 5. 5 ) 
 
 
Risk factors Male % Female % Total 
hypertension 82 41% 50 25% 66% 
diabetes 36 18% 20 10% 28% 
Hyper 
cholesterolemia* 
20 17% 8 7% 24% 
Non valvular 
atrialfibrillation 
- - - - - 
smoking 72 36% - - 36% 
alcohol 80 40% 2 1% 41% 
TIA 20 10% 8 4% 14% 
obesity 4 2% 8 4% 6% 
 
  * - for ischemic stroke only 
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  ONSET ( table 5 . 6 ) 
 
 
Onset Male Female Total 
sudden 84 46 65% 
gradual 56 14 35% 
 
            
            
             
 
 
  ACTIVITY OF ONSET ( table5 . 7 ) 
 
 
Activity of onset Thrombosis % Hemorrhage % 
On arising 64 44% 4 12% 
Stress 8 6% 6 16% 
Activities of daily living 72 50% 26 72% 
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CLINICAL PRESENTATION ( table 5 . 8 ) 
 
 
Clinical presentation 
 
Male % Female % Total 
Right hemiplegia 78 39% 26 13% 52% 
Left hemiplegia 44 22% 24 12% 34% 
Faciobrachial 
monoplegia 
8 4% 2 1% 5% 
TIA 8 4% 8 4% 8% 
Cerebellar symptoms 2 1% - - 1% 
 
 
 
 
     ASSOCIATED FEATURES ( table 5 . 9 ) 
 
 
 Thrombosis ICH Total % 
Loss of consciousness 40 12 52 26 
Seizures 12 8 20 10 
Bladder / bowel  involvement 48 8 56 28 
Hemianesthesia 6 2 8 4 
Headache 56 24 80 40 
Hemianopia 4 2 6 3 
Facial palsy 136 32 168 84 
Aphasia 82 12 94 47 
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       TIA ( table 5 . 10 ) 
 
 
 Male Female Total % 
Weakness / clumsiness 6 4 10 62 
Sensory symptoms 2 3 5 31 
Dysarthria 2 2 4 25 
Dysphasia 3 1 4 25 
Unsteadiness 1 - 1 6 
Vertigo 1 - 1 6 
 
 
 
CARDIAC LESIONS ASSOCIATED WITH STROKE ( table 5 . 11) 
 
 
 Male Female Total 
Rheumatic heart diseases 1 3 4 
Ischemic heart disease 10 5 15 
Mitral  valve prolapse 3 3 6 
Cardiomyopathies 8 2 10 
Aortic sclerosis 6 1 7 
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      ASSOCIATED  HISTORY OF OTHER DISEASES ( table 5 . 12) 
 
 
 
 Male Female Total 
Pulmonary tuberculosis 28 12 40 
Bronchial asthma 20 8 28 
COPD 18 2 20 
CRF 6 4 10 
Hepatic diseases 2 - 2 
Cardiac diseases 28 14 42 
Seizures 8 4 12 
Psychiatric disorders 2 - 2 
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CVT( table 5 . 13 ) 
 
  
2 Femalecases Case No.1 Case No. 2 
Age 28 26 
Focal neurological signs + + 
Headache + - 
Seizures - - 
papilloedema + + 
 
 
IMAGING ( table 5. 14 ) 
 
 
 Male Female Total 
Cerebral infarction 58 26 84 
Cortical atrophy 20 6 26 
Multiple infarct 16 4 20 
Normal 10 4 14 
Cerebellar infarct 2 - 2 
Intra cerebral hemorrhage 26 10 36 
Cerebral venous thrombosis* - 2 2 
 
    *confirmed by MRI brain 
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                                                      6 .  DATA  ANALYSIS 
 
 SEX DISTRIBUTION  ( table 5 . 1 ) 
 
           Of  the 200 cases studied the males affected were 140 in number while 
females were 60 cases   
The male : female ratio is 2.3 : 1 
 
AGE WISE DISTRIBUTION ( table 5 . 2 ) 
 
           young stroke (less than 40 years)  in this  study is 15 %.the maximum 
number of stroke occurred between 51 – 60 years is 34 %. The number of cases 
between  51 – 70 years  is  126 out of  200 which is maximum including both 
sexes (63%). The percentage  of cases below 30 and above 80 years is 5% , 3%  
respectively.   
INCIDENCE OF STROKES ( table5 . 3 )      
   
In this study  , Ischemic stroke is 81% ,  Intra cerebral hemorrhage 18 %, 
Cerebral venous thrombosis 1 %, subarachnoid hemorrhage 0% 
 
 TYPES OF STROKE ( table 5 . 4 )        
 
            Cerebral infarction including embolic stroke constituted 72 %. TIA was 
16 cases including 8 males , 8 females  patients constituted  8 %.there was 2 male 
cases. Cerebellar infarct also.  Intra cerebral hemorrhage was 18 %.They 
constituted 36 of 200 cases in both sexes. 
   Cerebral venous thrombosis also there which was 2 female cases. 
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 No cases of subarachnoid hemorrhage in this study. 
 
 
RISK FACTORS ( table 5 . 5 ) 
           Hypertension was the predominant risk factor  in about  66 %.   In this  
study  HT associated with ischemic stroke was 72%( 104 / 144 ). 28persons out of 
36 ICH had HT giving 77%.    
 In this study DM was present in 28% cases .  
 In patients with  ischemic stroke  Hypercholesterolemia  was present in 28 
out of 114 which constituted  24%.      
 There was no cases of  non valvular atrialfibrillation .    
  Smoking formed 36% in this study occupied entirely by males  
  82 of  200 cases were alcohol consumers of which 2 were female patients.
 Of these 200 cases 28 patients had TIA before this stroke , 20 males and 8    
females. 
 Obesity was present in 12 cases which 8 were females. 
 
 ONSET OF STROKE ( table 5 . 6 ) 
 
 Onset of stroke was sudden in 65% 
 
      The rest of  35% were gradual onset 
 
 
  ACTIVITY OF ONSET( table 5 . 7 ) 
 
68 patients developed stroke On arising while 14 persons stroke related to 
stress. For  98  patients stroke developed while on Activities of daily living. 
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   CLINICAL PRESENTATION ( table5 . 8 ) 
 
                 86% presented with weakness out of which 52% had Rightside 
Hemiplegia or hemiparesis, the remaining 34 % on left side. 10 patients presented 
with Faciobrachial monoplegia.  4% males and 4% females had TIA symptoms. 2 
patients had Cerebellar symptoms.         
  ASSOCIATED FEATURES ( table 5 . 9 ) 
               
                In this study   Loss of consciousness was present in  52 cases. 
                
               Seizures constituted 10%. 
 
            Bladder / bowel  involvement along with stroke was 56 cases. 
 
            Headache was present in 40 % 
 
              UMN type  Facial palsy involved  84% of stroke patients. 
 
              47 % patients were aphasic.      
   
             There was  symptoms of Hemianesthesia and Hemianopia in 4% 
and 3% cases respectively. 
  TIA ( table 5 . 10 ) 
 
      Both male  and  female patients presented with TIA symptoms most   
Weakness / clumsiness (62%) and other symptoms like Sensory  Symptoms   
(31%). Dysarthria (25%) , Dysphasia (25%), Unsteadiness(6%) Vertigo (6%). 
               
CARDIAC LESIONS ASSOCIATED WITH STROKE( table 5 . 11)  
  42 patients of 200 had cardiac lesions of these 28 were males  and 14 
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were females . Cardiac lesions   predominantly   present in males were of  
Ischemic heart disease, Cardiomyopathies , AorticSclerosis  where as females had   
Rheumatic heart diseases.  Mitral valve prolapse  was present in both sexes   
equally. 
 
    ASSOCIATED  HISTORY OF OTHER DISEASES ( table 5. 12) 
 
              Among 200 stroke cases , patients had  past history of other 
diseases also. Those were Pulmonary tuberculosis (40cases) , Bronchial asthma 
(28), COPD(20), CRF(10),  Hepatic diseases(2), Cardiac diseases(42 ),  
Seizures(12),  Psychiatric disorders(2) 
 
    CEREBRAL VENOUS THROMBOSIS ( table5 . 13)    
  
           2 female cases of   Cerebral venous thrombosis were present in this 
study. Both were postpartum by   14 days . One was 28 year old , another was 26. 
Both cases had  focal neurological signs and  papilloedema. One had headache. 
But no seizures.  
IMAGING ( table 5 . 14 ) 
 
           In this study, among 162 ischemic stroke, 84 patients had Cerebral 
infarction ,  Cortical atrophy was present in 26.  Multiple infarct was 20 in number 
whether 14 patients showed normal studies. 
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                                           7 . DISCUSSION 
 
      INCIDENCE 
 
              Dalal  P.M (1981) from japan studies showed that 4.5% medical  
admission were from stroke3. From this study it was about 5% (200 cases out of  
4000 admissions) 
      SEX 
 
            Sacco RL et al study showed  males had a greater frequency of stroke than 
Women 13 . In this  study also males affected greater than female. 
     AGE 
 
          In this study the stroke was maximum in the age group between  50 – 70 
year about 63%. In western countries the stroke was more in age 75 year 14 
Young stroke (less than 40 years) in  this study was 15%. According to 
Radhakrishnan study (1986) 15 it was 19% 
 
   RISK FACTORS 
 
           Hypertension was present in 66% of cases is this study.  Studies provided 
by Stroke registry in germany  by Arbeitsgruppe schalganfall hessen 16 showed 
hypertension associated stroke was 72% 
  In this study 28persons out of 36 ICH had HT giving 77%. According to 
Queshi AI, Suti MAK, Saflar K et al(1997)17 HT associated with ICH was 77% 
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  In this study HT associated with ischemic stroke was 72%. Study 
conducted by Nizam institute of medical sciences 18 Hyderabad showed 
HTassociated with   ischemic stroke was 62%      
  In this study DM was present in 28% cases;  research letters from C.foerch,  
T.neumann – haefelin et al(1997) 19 showed 27% diabetics among stroke  
   Hyper cholesterolemia present in this study was 24% among  ischemic 
stroke research letters from C.foerch,T.neumann – haefelin et al(1997) 19 showed 
hyper cholesterolemia  was 23% 
  Smoking formed 36% in this study. Sandercock et al 1989 20 showed 27%  
 
smoker among stroke patients. 
 
 The status of alcohol ingestion as a risk factor for ischemic stroke remains 
Controversial 21. Light  to moderate regular consumption of alcohol seems to be 
inversely related to carotid artery and systemic atherosclerosis.22    Acute &chronic 
heavy use of alcohol positively  correlate with incidence of ischemic stroke 
  In Honolulu heart study23, alcohol  consumption was associated with Intra  
 
cerebral hemorrhage.         
   
    In this study   previous TIA was 12% among stroke patients. In  
oxfordshire community project  Sandercock et al 1989 20 showed TIA was 14 %. 
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     ACTIVITY OF ONSET 
 
Thrombotic stroke In this study MRSR study 24 
On arising 44% 42% 
Stress 6% 2% 
Activities of daily living 50% 56% 
 
 
 
Intra cerebral hemorrhage In this study MRSR study 24 
On arising 12% 18% 
Stress 16% 15% 
Activities of daily living 72% 67% 
 
 
 
 
 
SIDE OF LESION 
 
Side of lesion 
 
In this study Other study 19 
Left 60% 40% 
Right 56% 44% 
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  FEATURES OF TIA 
 
 
Features of TIA In this study Other study 25 
Weakness / clumsiness 62% 50% 
Sensory symptoms 31% 35% 
Dysarthria 25% 23% 
Dysphasia 25% 18% 
Unsteadiness 6% 12% 
Vertigo 6% 5% 
 
 
 
 
CARDIAC LESIONS ASSOCIATED WITH STROKE    
             
             In this study , stroke patients with cardiac lesion were 21% . In arabian      
stroke study 26 cardiac causes were 11%.  
              In stroke data bank 1986 27 study cardiac causes were 23% 
                    
 
CVT 
 
      Here both CVT cases were puerperial women. Average age was 27. Where as 
study  from Cantu C , barinagarrementeria F et al 28 showed average age was for 
CVT in  puerperial women is 26 years 
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     8  . CONCLUSION    
   
Stroke   commonly   affecting   males   than   females.   
  More chance for getting stroke in the age group between 51 – 
70 years. Young stroke was also commonly occurring.    
 Ischemic stroke was more common than hemorrhagic stroke.  
 Cerebral venous thrombosis occurred in the puerperial women 
 No cases of subarachnoid hemorrhage in this study.  
Hypertension was the predominant risk factor.     
 DM was also present.         
 Hypercholesterolemia was associated with in patients with   
ischemic stroke.         
  Smoking , alcoholism , and obesity were also important risk factor. 
  Onset of stroke was sudden in most of the cases. 
 Stroke developed while on Activities of daily living , then stress  
  Hemiplegia or hemiparesis was the commonest presentation 
  Loss of consciousness ,  Bladder / bowel  involvement , UMN type  
Facial palsy , Aphasia was commonly associated features.    
  Patients were also presented with TIA symptoms.   
  Stroke patients had cardiac lesions like IHD , RHD , DCMP , MVP, 
Aortic sclerosis.          
  Various medical diseases also  were present in stroke patients also.  
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    Stroke caused  by  Cerebral venous thrombosis commonly occurred 
in  the young females in puerperial period.      
  In imaging studies ,Cerebral infarction was the common finding. 
Others were Cortical atrophy, Multiple infarct. Some patients showed normal 
studies. 
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  10 . PROFORMA        
 Name :           
  Age   :  Sex   :     Ip No  :    
 Address   :       occupation   :   
            
  Chief complaints  :        
            
  History of present illness  :       
            
    Onset        
    Activity of onset       
   Associated features       
            
   Past History   :     HT / DM / TIA / PT / BA / COPD / CRF 
/ CAHD / DCMP / RHD / AS / MVP / Hepatic diseases / Seizures / Psychiatric 
disorders            
        Personal History   :  Smoking  / Alcoholism / Diet   
  General examination         
  Vital signs   :  pulse rate /  blood pressure     
  Clinical examination       
  Clinical diagnosis         
      59      
  Investigations  :        
   Urine albumin       
    sugar        
    deposits       
   blood DC / TC / Hb /ESR      
   blood sugar        
    urea        
    creatinine       
    electrolytes ,        
    total cholesterol      
   ECG         
   Xray Chest        
   ECHO        
   Special investigations for associated diseases   
   CT Brain         
    plain        
    contrast (if necessary)     
   MRI Brain (if necessary)      
            
  Final Diagnosis     
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Serial no / Age / Sex / CP - Clinical presentation ( RHP - Right hemiplegia , LHP - 
Left hemiplegia , FBM - Faciobrachial monoplegia , TIA - Transient ischaemic 
attack  , CS - Cerebellar symptoms ) / On – onset ( s – sudden , G – gradual ) / A.f 
- Associated features ( Fp - Facial palsy , A – Aphasia ) / Ca - Cardiac lesions 
associated with stroke  ( RHD - Rheumatic heart diseases , IHD - Ischemic heart 
disease , MVP -Mitral  valve prolapse ,DCMP – Dilated Cardiomyopathies , AS -
Aortic sclerosis )  / HT – hypertension  / DM – diabetes / HC - Hyper 
cholesterolemia /  Sm – smoking / Al – alcohol / CT – CT brain ( I - Cerebral 
infarction , ICH - Intra cerebral hemorrhage , N – normal , MI - Multiple infarct 
CA - Cortical atrophy , CVT - Cerebral venous thrombosis ) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
